Trials / Unknown
UnknownNCT05882461
An E-health Letter Intervention for Caregivers
90Second Caregiver: A Randomized Control Trial of an E-health Letter for Caregivers
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 330 (estimated)
- Sponsor
- IWK Health Centre · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the present study is to conduct a two-arm Randomized Control Trial (RCT) comparing individuals receiving the 90Second Caregiver health letter, with a usual care (routine care received by caregivers) control group. The goals of the present study are: * To evaluate the effectiveness of the 90Second Caregiver health letter in improving caregiver's self-efficacy (primary outcome), savouring, and quality of life (secondary outcomes). * To evaluate the effectiveness of the 90Second Caregiver health letter in reducing caregiver's psychological strain and caregiver burden (secondary outcomes). * To examine the impact of levels of engagement with the 90Second Caregiver health letter on primary and secondary outcomes. * To assess the usability of the 90Second Caregiver health letter, as it relates to the relevance of topic, user friendliness, and appropriateness of the readability levels. * To evaluate psychometric properties of self-constructed measures in 90Second newsletter.
Detailed description
The present study will examine the effectiveness of the 90Second Caregiver health letter in increasing self-efficacy in a sample of informal caregivers of ABI survivors in Nova Scotia. Participants in this study will be recruited from the Caring Forward Trials within Cohort Study (REB#1025253). The study is funded by the Nova Scotia Department of Health and Wellness.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | 90Second Caregiver health letter | Participant receives the weekly health letter via email |
Timeline
- Start date
- 2021-02-17
- Primary completion
- 2024-03-01
- Completion
- 2024-03-01
- First posted
- 2023-05-31
- Last updated
- 2023-05-31
Locations
1 site across 1 country: Canada
Source: ClinicalTrials.gov record NCT05882461. Inclusion in this directory is not an endorsement.